Diclofenac Sodium
Total Payments
$218,780
Transactions
3
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $218,780 | 3 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $218,780 | 3 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| 11800105 | Mylan Pharmaceuticals Inc. | $218,780 | 0 |
Top Doctors Receiving Payments for Diclofenac Sodium
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Pittsburgh, PA | $218,780 | 3 |
Ad
Manufacturing Companies
- Mylan Pharmaceuticals Inc. $218,780
Product Information
- Type Drug
- Total Payments $218,780
- Total Doctors 0
- Transactions 3
About Diclofenac Sodium
Diclofenac Sodium is a drug associated with $218,780 in payments to 0 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is Mylan Pharmaceuticals Inc..
Payment data is available from 2019 to 2019. In 2019, $218,780 was paid across 3 transactions to 0 doctors.
The most common payment nature for Diclofenac Sodium is "Unspecified" ($218,780, 100.0% of total).
Diclofenac Sodium is associated with 1 research study, including "11800105" ($218,780).